06:51 EDT Eli Lilly to acquire Morphic for $57 per share in cash
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
- Ozempic shown in JAMA study to lower obesity-associated cancer risk
- Eli Lilly call volume above normal and directionally bullish
- Morgan Stanley says impact to Lilly GLP-1 opportunity from NAION link ‘very low’
- BMO: Eli Lilly’s (NYSE:LLY) Alzheimer’s Drug Could Boost Sales by $7.1B